About AIM ImmunoTech (AIM)
AIM ImmunoTech Inc. is an immuno-pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship produc... Read more
- USD1.25
- USD1.25
- USD1.06
- 1.52M
Stock News
43 minutes ago
Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill
MarketWatch
1 hour ago
Why Arm Holdings Stock Was Moving Higher Again Today
Yahoo
3 hours ago
Jennifer Garner's Once Upon a Farm opens at $21 per share in market debut, after pricing IPO at $18
CNBC
4 hours ago
Cramer calls this drug maker the 'greatest growth stock.' He also names a runner-up
CNBC